Subscribe to get important updates and helpful insights delivered straight to your inbox.
Explore our proprietary Small Mobile Stem (SMS) cell technology
Review our pre-clinical proof-of-concept and safety studies
Track our groundbreaking Phase I clinical trial targeting COPD.
Our friendly team would love to hear from you.